About Biochip
Biochips are bio-microsystems. Bio-microsystems are small integrated devices used for biochemical reactions, biological monitoring, research, academic studies, drug discovery, and much more. In simple terms, biochips are small sized chips that can perform multiple (generally thousands) biochemical reactions parallelly. A collection of microarrays or micro-test sites form these biochips. Microarrays when arranged on a surface made up of either glass or silicon, can perform large numbers of tests at the same. Thus, they help in cost and time saving.
Technavio’s analysts forecast the global biochip market to grow at a CAGR of 17.53% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global biochip market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
• APAC
• Europe
• North America
• ROW
Technavio's report, Global Biochip Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott
• Agilent Technologies
• Illumina
• PerkinElmer
• Thermo Fisher Scientific
Other prominent vendors
• BioChain
• Bio-Rad Laboratories
• Cepheid
• EMD Millipore
• Fluidigm
• SuperBioChips Laboratories
• US Biomax
Market driver
• Increase in market presence with collaboration strategy
• For a full, detailed list, view our report
Market challenge
• Standardization and accuracy issues
• For a full, detailed list, view our report
Market trend
• Growth in bioinformatics software industry
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
• Market size and forecast
• Five forces analysis
PART 05: Market segmentation by fabrication technology
• Global biochip market by microarrays
• Global biochip market by microfluidics
PART 06: Geographical segmentation
• Biochip market in Americas
• Biochip market in EMEA
• Biochip market in APAC
PART 07: Decision framework
PART 08: Drivers and challenges
• Market drivers
• Market challenges
PART 09: Market trends
• Increasing POC diagnostics
• Growing application of biochips in pharmacogenomics
• Rise in vendors' strategic initiatives
• Increasing use of biochip technology as alternative to animal testing
PART 10: Vendor landscape
• Competitive scenario
• Investment opportunity
PART 11: Key vendor analysis
• Agilent Technologies
• GE Healthcare
• PerkinElmer
• Thermo Fisher Scientific
• Other prominent vendors
PART 12: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Types of biochips and their applications
Exhibit 02: The biochip platform
Exhibit 03: Global biochip market: Overview
Exhibit 04: Global biochip market 2016-2021 ($ billions)
Exhibit 05: Significance of biochip in different sectors
Exhibit 06: Factors impacting global biochip market
Exhibit 07: Five forces analysis
Exhibit 08: Global biochip market by fabrication technology 2016-2021 (% share)
Exhibit 09: Global biochip market by fabrication technology: Snapshot
Exhibit 10: Global biochip market by microarrays 2016-2021 ($ billions)
Exhibit 11: Applications of DNA microarrays
Exhibit 12: Global biochip market by microfluidics 2016-2021 ($ billions)
Exhibit 13: Applications of lab-on-a-chip
Exhibit 14: Global biochip market by geography 2016-2021 (% share)
Exhibit 15: Global biochip market by geography: Snapshot
Exhibit 16: Growth perspective in developed and developing market
Exhibit 17: Biochip market in Americas 2016-2021 ($ billions)
Exhibit 18: Programs held by companies in global biochip market
Exhibit 19: Biochip market in EMEA 2016-2021 ($ billions)
Exhibit 20: Biochip market in APAC 2016-2021 ($ billions)
Exhibit 21: Biochips in testing agriculture products
Exhibit 22: Major chronic disease-related deaths 2012 (in thousands)
Exhibit 23: Strategic success factors for vendors
Exhibit 24: Investment opportunity mapping
Exhibit 25: Agilent Technologies: Profile
Exhibit 26: Agilent Technologies: Strength analysis
Exhibit 27: Agilent Technologies: Strategy assessment
Exhibit 28: Agilent Technologies: Opportunity assessment
Exhibit 29: GE Healthcare: Profile
Exhibit 30: GE Healthcare: Strength analysis
Exhibit 31: GE Healthcare: Strategy assessment
Exhibit 32: GE Healthcare: Opportunity assessment
Exhibit 33: PerkinElmer: Profile
Exhibit 34: PerkinElmer: Strength analysis
Exhibit 35: PerkinElmer: Strategy assessment
Exhibit 36: PerkinElmer: Opportunity assessment
Exhibit 37: Thermo Fisher Scientific: Profile
Exhibit 38: Thermo Fisher Scientific: Strength analysis
Exhibit 39: Thermo Fisher Scientific: Strategy assessment
Exhibit 40: Thermo Fisher Scientific: Opportunity assessment
